InMed Pharmaceuticals Inc. (MTRI): Form 8-K filed 2026-09-18
- Accepted by EDGAR
- 2026-09-18 17:11 ET
- Event date
- 2026-09-16
- Accession no.
- 0001213900-26-101492
- Original filing
- SEC EDGAR filing index
Items reported
- Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
The company received notice from its exchange that it does not satisfy a continued listing rule (for example a minimum bid price or filing requirement), or it decided to delist or transfer its listing. - Item 8.01: Other Events
A voluntary disclosure of an event the company considers important to security holders that no other Item covers, such as a dividend declaration, a buyback program, litigation updates or product news. - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | CURRENT REPORT | ea0305769-8k_inmed.htm |
| EX-99.1 | PRESS RELEASE | ea030576901ex99-1.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.